CFGA
ABBV icon

Cambridge Financial Group (Arizona)’s AbbVie ABBV Stock Holding History

Cambridge Financial Group (Arizona)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630K Sell
2,503
-1
-0% -$215 0.2% 85
2026
Q1 		$545K Buy
2,504
+30
+1% +$6.66K 0.18% 96
2025
Q4 		$451K Sell
2,474
-29
-1% -$6.61K 0.16% 107
2025
Q3 		$579K Hold
2,503
– – 0.19% 91
2025
Q2 		$465K Sell
2,503
-191
-7% -$35.5K 0.17% 88
2025
Q1 		$563K Buy
2,694
+214
+9% +$41.6K 0.24% 73
2024
Q4 		$441K Sell
2,480
-54
-2% -$9.93K 0.19% 81
2024
Q3 		$500K Buy
2,534
+220
+10% +$41.1K 0.21% 79
2024
Q2 		$397K Hold
2,314
– – 0.18% 82
2024
Q1 		$421K Sell
2,314
-1
-0% -$172 0.2% 77
2023
Q4 		$359K Buy
+2,315
New +$338K 0.19% 81

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Financial Group (Arizona)'s ABBV Position: Q2 2026 in Review

Cambridge Financial Group (Arizona) reduced its AbbVie (ABBV) stake by 0.04% in Q2 2026, selling an estimated $215 and leaving 2,503 shares worth $630K. The position accounts for 0.2% of the portfolio, ranked #85.

Cambridge Financial Group (Arizona) first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cambridge Financial Group (Arizona) held 2,503 shares of AbbVie worth $630K as of Q2 2026.
  • Cambridge Financial Group (Arizona) sold 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.2% of Cambridge Financial Group (Arizona)'s portfolio in Q2 2026, its #85 holding.
  • Cambridge Financial Group (Arizona) first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cambridge Financial Group (Arizona)'s 13F filing for Q2 2026, filed 14 Jul 2026.